HPLC and mass spectrometry: what each method actually confirms

A certificate of analysis for a research peptide typically reports two analytical results: a purity figure from liquid chromatography and a mass confirmation from mass spectrometry. They are frequently read as two ways of saying the same thing. They are not. Each answers a question the other cannot.

What chromatography establishes

Reversed-phase high-performance liquid chromatography separates a mixture by how strongly each component partitions between a nonpolar stationary phase and a polar mobile phase. Components that interact more strongly with the column elute later. A detector at the column outlet records what passes, and the resulting trace is the chromatogram.

Purity is calculated as the proportion of total detected signal represented by the main peak:

Chromatographic purity
purity % = (area of the main peak / total peak area) x 100

What this establishes is homogeneity. It tells you that the ultraviolet-absorbing material in the sample is, to the stated degree, one thing rather than several. That is a real and useful statement.

What it does not establish

Chromatography does not identify what that one thing is. A peak is a peak. Its retention time is characteristic under a given method, but retention time alone is weak evidence of identity, and it is not evidence at all when compared across different methods.

It also only sees what the detector responds to. At 214 nm the detector responds to the peptide bond, which is why that wavelength is standard for peptide work. At 280 nm it responds mainly to aromatic side chains. The same sample analyzed at both wavelengths yields two different purity figures, and neither is wrong.

Anything that does not absorb at the detection wavelength is invisible. Water, salts and counterions all fall into that category, which is why chromatographic purity says nothing about how much of the vial is peptide.

What mass spectrometry establishes

Electrospray ionization transfers peptide molecules into the gas phase as charged species, and the analyzer separates them by mass-to-charge ratio. The measured mass is then compared against the mass calculated from the sequence.

Agreement within instrument tolerance confirms that the material has the expected molecular mass. That is a far stronger identity statement than retention time, because mass is an intrinsic property of the molecule rather than a property of the separation.

Reading a discrepancy

A mismatch is informative rather than simply a failure, and the size of the difference often indicates the cause.

• An increase of around 16 units suggests oxidation, most commonly at methionine.
• A difference matching the residue mass of a single amino acid suggests a deletion sequence, a common synthesis byproduct where one coupling step failed.
• An increase of around 1 unit suggests deamidation, where asparagine or glutamine has converted to the corresponding acid.

One point of care: average mass and monoisotopic mass are different numbers, and comparing an observed monoisotopic value against a theoretical average value produces a mismatch that does not exist. A certificate should state which convention it uses.

What it does not establish

Mass spectrometry confirms mass, not sequence order. Two peptides made from the same residues in a different order have identical molecular mass. Distinguishing them requires fragmentation, which is a different experiment and is rarely part of a routine release certificate.

It is also poorly suited to quantifying purity. Ionization efficiency varies between species, so peak intensity in a mass spectrum is not proportional to abundance in the sample. A minor impurity that ionizes well can appear more prominent than a major component that does not.

Why both are needed

The two methods fail in opposite directions, which is precisely why they are run together.

Chromatography alone can report a very high purity figure for a homogeneous sample of the wrong compound. Mass spectrometry alone can confirm the correct mass in a sample where the target represents a modest fraction of the material present.

Run together, chromatography answers how much of the detected material is one thing, and mass spectrometry answers whether that thing is what it should be. Neither question is optional.

What neither method answers

Both are blind to how much of the physical material in the vial is peptide. That figure comes from net peptide content, determined by amino acid analysis or nitrogen determination:

Net peptide content
net peptide % = (mass of peptide / total mass of lyophilizate) x 100

The remainder is water and counterion, most often trifluoroacetate carried through from reversed-phase purification. A lot can be highly homogeneous by chromatography, correct by mass, and still be a minority of peptide by weight.

Any calculation involving quantity depends on that third figure. It is also the one most often absent from certificates in circulation.

Reading the method section

A purity figure without its method is difficult to interpret and impossible to compare. The parameters worth finding on a certificate are the column chemistry and dimensions, the mobile phase composition, the gradient profile, the flow rate and the detection wavelength. For the mass section, the ionization technique and whether the reported theoretical mass is average or monoisotopic.

Where a chromatogram is reproduced, it is worth looking at directly. Peak symmetry, baseline quality and the position of minor peaks are visible there and nowhere in the summary figure.

[chm_ruo_note]